Open Site Navigation
  • LinkedIn
  • Twitter

Expansion Therapeutics News:

READ THE RELEASE

Successful A Round Funding & Next Steps

Site Under Construction

Transformative Oral Medicines for Severe RNA-Mediated Diseases

Small molecules, big difference

Expansion Therapeutics has significantly expanded on scientific founder Matt Disney’s breakthrough work in addressing Small Molecules interacting with RNA (SMiRNA).

The World of SMiRNA™

Targeting RNA, Curing Disease

for Major Neurological Diseases

© 2021 Expansion Therapeutics     |    Terms of Use    |    Privacy Policy    |    info@expansionrx.com

LOCATIONS:

Headquarters

Boston, MA

Research

Jupiter, FL